Today, NORML and it’s national network of advocacy chapters released a memo to state lawmakers, regulators, prosecutors, and other interested parties providing guidance for how they can take emergency actions to better promote the health and […]
Tag: NORML
Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. A team of researchers from […]
Poll: Majority of Americans Favor Designating Cannabis Dispensaries as “Essential Services”
A majority of Americans agree with states’ decisions to classify licensed medical cannabis facilities as “essential services” to the community – a designation that permits them to maintain retail operations during regional ‘stay-at-home’ orders. Nationwide […]
NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”
For the second time in four years, the US Drug Enforcement Administration is proposing regulatory changes to procedures governing the federally licensed manufacture of cannabis for clinical research purposes. In a Notice of Proposed Rulemaking, […]